Shares of Glenmark Life Sciences, a number one developer and producer of choose high-value prescription drugs, will likely be listed on BSE and NSE on Friday, August 6. The Glenmark Life Sciences Preliminary Public Providing is presently at a premium of round 13 per cent in Gray. The IPO GMP of Glenmark Life Sciences earlier than itemizing is Rs 85. The shares of Glenmark Life Sciences will likely be listed on Bombay Inventory Change and Nationwide Inventory Change at 10 am.
In keeping with market consultants, buyers can get a list achieve of round 15 to twenty %. Glenmark Life Sciences is a completely owned subsidiary of Glenmark Prescribed drugs. The Glenmark Life Sciences IPO obtained bids for 66.33 crore (66,33,24,160) shares in opposition to a complete situation dimension of 1.50 crore (1,50,18,279) shares. The value band was fastened at Rs 695-720 per share. The allotment was made at Rs 720 per share.
In case you have any considerations or complaints relating to this text, please tell us and the article will likely be eliminated quickly.